ArticleNanotheranostics2022

Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma.

Cario Wing-Sze Lo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.